Efficacy and Safety of Eltrombopag in Chinese Patients with Refractory or Relapsed Severe Aplastic Anemia

The Phase II multicenter trial investigated the efficacy and safety of eltrombopag in 20 adult Chinese patients with refractory or relapsed severe aplastic anemia.
[Scientific Reports]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News